HISPANA | Directorio nacional de recursos digitales > Dades de registre

Está en:  › Dades de registre

Linked Open Data

A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure

Identificadores del recurso

alvarez-Garcia J, Garcia-Osuna A, Vives-Borras M, Ferrero-Gregori A, Martinez-Selles M, Vazquez R, et al. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Front Physiol. 2021 Oct 22;12:708890.

https://hdl.handle.net/20.500.13003/19399

10.3389/fphys.2021.708890

1664-042X

34744758

L636379719

2-s2.0-85118711903

716498400001

Procedència

(Docusalut. Repositorio institucional del sistema sanitario público de las Islas Baleares)

Fitxa

Títol:: A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure
Tema:: biomarker (BM); panel (C33); acute heart failure (AHF); risk stratification; prognosis
Descripció:: Introduction and Objectives: Most multi-biomarker strategies in acute heart failure (HF) have only measured biomarkers in a single-point time. This study aimed to evaluate the prognostic yielding of NT-proBNP, hsTnT, Cys-C, hs-CRP, GDF15, and GAL-3 in HF patients both at admission and discharge. Methods: We included 830 patients enrolled consecutively in a prospective multicenter registry. Primary outcome was 12-month mortality. The gain in the C-index, calibration, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) was calculated after adding each individual biomarker value or their combination on top of the best clinical model developed in this study (C-index 0.752, 0.715-0.789) and also on top of 4 currently used scores (MAGGIC, GWTG-HF, Redin-SCORE, BCN-bioHF). Results: After 12-month, death occurred in 154 (18.5%) cases. On top of the best clinical model, the addition of NT-proBNP, hs-CRP, and GDF-15 above the respective cutoff point at admission and discharge and their delta during compensation improved the C-index to 0.782 (0.747-0.817), IDI by 5% (p < 0.001), and NRI by 57% (p < 0.001) for 12-month mortality. A 4-risk grading categories for 12-month mortality (11.7, 19.2, 26.7, and 39.4%, respectively; p < 0.001) were obtained using combination of these biomarkers. Conclusion: A model including NT-proBNP, hs-CRP, and GDF-15 measured at admission and discharge afforded a mortality risk prediction greater than our clinical model and also better than the most currently used scores. In addition, this 3-biomarker panel defined 4-risk categories for 12-month mortality.; This work was supported by grants from Redes Tematicas de Investigacion Cooperativa en Salud del Instituto de Salud Carlos III (REDINSCOR), Madrid, Spain (grant no. RD06-0003-0000) and Red de Investigacion Cardiovascular del Instituto de Salud Carlos III (RIC), Madrid, Spain (grant no. RD12/0042/0002).
Idioma:: English
Autor/Productor:: alvarez-Garcia, Jesus; Garcia-Osuna, Alvaro; Vives-Borrás, Miquel; Ferrero-Gregori, andreu; Martinez-Selles, Manuel; Vazquez, Rafael; Gonzalez-Juanatey, Jose R.; Rivera, Miguel; Segovia, Javier; Pascual-Figal, Domingo; Bover, Ramon; Bascompte, Ramon; Delgado, Juan; Grau-Sepúlveda, Andrés; Bardaji, Alfredo; Perez-Villa, Felix; Zamorano, Jose Luis; Crespo-Leiro, Marisa; Sanchez, Pedro Luis; Ordonez-Llanos, Jordi; Cinca, Juan; Spanish Heart Failure Network
Editor:: Frontiers Media Sa
Drets:: Attribution 4.0 International; http://creativecommons.org/licenses/by/4.0/; open access
Data:: 2023-09-26T17:55:41Z; 2021-10-22
Tipo de recurso:: research article
Format:: application/pdf

oai_dc

Descarregar XML

<?xml version="1.0" encoding="UTF-8" ?>

<oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
1. <dc:title>A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure</dc:title>
2. <dc:creator>alvarez-Garcia, Jesus</dc:creator>
3. <dc:creator>Garcia-Osuna, Alvaro</dc:creator>
4. <dc:creator>Vives-Borrás, Miquel</dc:creator>
5. <dc:creator>Ferrero-Gregori, andreu</dc:creator>
6. <dc:creator>Martinez-Selles, Manuel</dc:creator>
7. <dc:creator>Vazquez, Rafael</dc:creator>
8. <dc:creator>Gonzalez-Juanatey, Jose R.</dc:creator>
9. <dc:creator>Rivera, Miguel</dc:creator>
10. <dc:creator>Segovia, Javier</dc:creator>
11. <dc:creator>Pascual-Figal, Domingo</dc:creator>
12. <dc:creator>Bover, Ramon</dc:creator>
13. <dc:creator>Bascompte, Ramon</dc:creator>
14. <dc:creator>Delgado, Juan</dc:creator>
15. <dc:creator>Grau-Sepúlveda, Andrés</dc:creator>
16. <dc:creator>Bardaji, Alfredo</dc:creator>
17. <dc:creator>Perez-Villa, Felix</dc:creator>
18. <dc:creator>Zamorano, Jose Luis</dc:creator>
19. <dc:creator>Crespo-Leiro, Marisa</dc:creator>
20. <dc:creator>Sanchez, Pedro Luis</dc:creator>
21. <dc:creator>Ordonez-Llanos, Jordi</dc:creator>
22. <dc:creator>Cinca, Juan</dc:creator>
23. <dc:creator>Spanish Heart Failure Network</dc:creator>
24. <dc:subject>biomarker (BM)</dc:subject>
25. <dc:subject>panel (C33)</dc:subject>
26. <dc:subject>acute heart failure (AHF)</dc:subject>
27. <dc:subject>risk stratification</dc:subject>
28. <dc:subject>prognosis</dc:subject>
29. <dc:description>Introduction and Objectives: Most multi-biomarker strategies in acute heart failure (HF) have only measured biomarkers in a single-point time. This study aimed to evaluate the prognostic yielding of NT-proBNP, hsTnT, Cys-C, hs-CRP, GDF15, and GAL-3 in HF patients both at admission and discharge. Methods: We included 830 patients enrolled consecutively in a prospective multicenter registry. Primary outcome was 12-month mortality. The gain in the C-index, calibration, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) was calculated after adding each individual biomarker value or their combination on top of the best clinical model developed in this study (C-index 0.752, 0.715-0.789) and also on top of 4 currently used scores (MAGGIC, GWTG-HF, Redin-SCORE, BCN-bioHF). Results: After 12-month, death occurred in 154 (18.5%) cases. On top of the best clinical model, the addition of NT-proBNP, hs-CRP, and GDF-15 above the respective cutoff point at admission and discharge and their delta during compensation improved the C-index to 0.782 (0.747-0.817), IDI by 5% (p < 0.001), and NRI by 57% (p < 0.001) for 12-month mortality. A 4-risk grading categories for 12-month mortality (11.7, 19.2, 26.7, and 39.4%, respectively; p < 0.001) were obtained using combination of these biomarkers. Conclusion: A model including NT-proBNP, hs-CRP, and GDF-15 measured at admission and discharge afforded a mortality risk prediction greater than our clinical model and also better than the most currently used scores. In addition, this 3-biomarker panel defined 4-risk categories for 12-month mortality.</dc:description>
30. <dc:description>This work was supported by grants from Redes Tematicas de Investigacion Cooperativa en Salud del Instituto de Salud Carlos III (REDINSCOR), Madrid, Spain (grant no. RD06-0003-0000) and Red de Investigacion Cardiovascular del Instituto de Salud Carlos III (RIC), Madrid, Spain (grant no. RD12/0042/0002).</dc:description>
31. <dc:date>2023-09-26T17:55:41Z</dc:date>
32. <dc:date>2023-09-26T17:55:41Z</dc:date>
33. <dc:date>2021-10-22</dc:date>
34. <dc:type>research article</dc:type>
35. <dc:identifier>alvarez-Garcia J, Garcia-Osuna A, Vives-Borras M, Ferrero-Gregori A, Martinez-Selles M, Vazquez R, et al. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Front Physiol. 2021 Oct 22;12:708890.</dc:identifier>
36. <dc:identifier>https://hdl.handle.net/20.500.13003/19399</dc:identifier>
37. <dc:identifier>10.3389/fphys.2021.708890</dc:identifier>
38. <dc:identifier>1664-042X</dc:identifier>
39. <dc:identifier>34744758</dc:identifier>
40. <dc:identifier>L636379719</dc:identifier>
41. <dc:identifier>2-s2.0-85118711903</dc:identifier>
42. <dc:identifier>716498400001</dc:identifier>
43. <dc:language>eng</dc:language>
44. <dc:rights>Attribution 4.0 International</dc:rights>
45. <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
46. <dc:rights>open access</dc:rights>
47. <dc:format>application/pdf</dc:format>
48. <dc:publisher>Frontiers Media Sa</dc:publisher>
</oai_dc:dc>

didl

Descarregar XML

<?xml version="1.0" encoding="UTF-8" ?>

<d:DIDL schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
1. <d:DIDLInfo>
  1. <dcterms:created schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2023-09-26T17:55:41Z</dcterms:created>
  </d:DIDLInfo>
2. <d:Item id="hdl_20.500.13003_19399">
  1. <d:Descriptor>
    1. <d:Statement mimeType="application/xml; charset=utf-8">
      1. <dii:Identifier schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:20.500.13003/19399</dii:Identifier>
      </d:Statement>
    </d:Descriptor>
  2. <d:Descriptor>
    1. <d:Statement mimeType="application/xml; charset=utf-8">
      1. <oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
        <dc:title>A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure</dc:title>
        <dc:creator>alvarez-Garcia, Jesus</dc:creator>
        <dc:creator>Garcia-Osuna, Alvaro</dc:creator>
        <dc:creator>Vives-Borrás, Miquel</dc:creator>
        <dc:creator>Ferrero-Gregori, andreu</dc:creator>
        <dc:creator>Martinez-Selles, Manuel</dc:creator>
        <dc:creator>Vazquez, Rafael</dc:creator>
        <dc:creator>Gonzalez-Juanatey, Jose R.</dc:creator>
        <dc:creator>Rivera, Miguel</dc:creator>
        <dc:creator>Segovia, Javier</dc:creator>
        <dc:creator>Pascual-Figal, Domingo</dc:creator>
        <dc:creator>Bover, Ramon</dc:creator>
        <dc:creator>Bascompte, Ramon</dc:creator>
        <dc:creator>Delgado, Juan</dc:creator>
        <dc:creator>Grau-Sepúlveda, Andrés</dc:creator>
        <dc:creator>Bardaji, Alfredo</dc:creator>
        <dc:creator>Perez-Villa, Felix</dc:creator>
        <dc:creator>Zamorano, Jose Luis</dc:creator>
        <dc:creator>Crespo-Leiro, Marisa</dc:creator>
        <dc:creator>Sanchez, Pedro Luis</dc:creator>
        <dc:creator>Ordonez-Llanos, Jordi</dc:creator>
        <dc:creator>Cinca, Juan</dc:creator>
        <dc:creator>Spanish Heart Failure Network</dc:creator>
        <dc:description>Introduction and Objectives: Most multi-biomarker strategies in acute heart failure (HF) have only measured biomarkers in a single-point time. This study aimed to evaluate the prognostic yielding of NT-proBNP, hsTnT, Cys-C, hs-CRP, GDF15, and GAL-3 in HF patients both at admission and discharge. Methods: We included 830 patients enrolled consecutively in a prospective multicenter registry. Primary outcome was 12-month mortality. The gain in the C-index, calibration, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) was calculated after adding each individual biomarker value or their combination on top of the best clinical model developed in this study (C-index 0.752, 0.715-0.789) and also on top of 4 currently used scores (MAGGIC, GWTG-HF, Redin-SCORE, BCN-bioHF). Results: After 12-month, death occurred in 154 (18.5%) cases. On top of the best clinical model, the addition of NT-proBNP, hs-CRP, and GDF-15 above the respective cutoff point at admission and discharge and their delta during compensation improved the C-index to 0.782 (0.747-0.817), IDI by 5% (p < 0.001), and NRI by 57% (p < 0.001) for 12-month mortality. A 4-risk grading categories for 12-month mortality (11.7, 19.2, 26.7, and 39.4%, respectively; p < 0.001) were obtained using combination of these biomarkers. Conclusion: A model including NT-proBNP, hs-CRP, and GDF-15 measured at admission and discharge afforded a mortality risk prediction greater than our clinical model and also better than the most currently used scores. In addition, this 3-biomarker panel defined 4-risk categories for 12-month mortality.</dc:description>
        <dc:date>2023-09-26T17:55:41Z</dc:date>
        <dc:date>2023-09-26T17:55:41Z</dc:date>
        <dc:date>2021-10-22</dc:date>
        <dc:type>research article</dc:type>
        <dc:identifier>alvarez-Garcia J, Garcia-Osuna A, Vives-Borras M, Ferrero-Gregori A, Martinez-Selles M, Vazquez R, et al. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Front Physiol. 2021 Oct 22;12:708890.</dc:identifier>
        <dc:identifier>https://hdl.handle.net/20.500.13003/19399</dc:identifier>
        <dc:identifier>10.3389/fphys.2021.708890</dc:identifier>
        <dc:identifier>1664-042X</dc:identifier>
        <dc:identifier>34744758</dc:identifier>
        <dc:identifier>L636379719</dc:identifier>
        <dc:identifier>2-s2.0-85118711903</dc:identifier>
        <dc:identifier>716498400001</dc:identifier>
        <dc:language>eng</dc:language>
        <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
        <dc:rights>open access</dc:rights>
        <dc:rights>Attribution 4.0 International</dc:rights>
        <dc:publisher>Frontiers Media Sa</dc:publisher>
        </oai_dc:dc>
      </d:Statement>
    </d:Descriptor>
  3. <d:Component id="20.500.13003_19399_1">
    1. <d:Resource mimeType="application/pdf" ref="https://docusalut.com/bitstreams/5a8b84b1-6ed7-4c7d-845e-d7ffd3ff8292/download" />
    </d:Component>
  </d:Item>
</d:DIDL>

dim

Descarregar XML

<?xml version="1.0" encoding="UTF-8" ?>

<dim:dim schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
1. <dim:field element="contributor" mdschema="dc" qualifier="author">alvarez-Garcia, Jesus</dim:field>
2. <dim:field element="contributor" mdschema="dc" qualifier="author">Garcia-Osuna, Alvaro</dim:field>
3. <dim:field element="contributor" mdschema="dc" qualifier="author">Vives-Borrás, Miquel</dim:field>
4. <dim:field element="contributor" mdschema="dc" qualifier="author">Ferrero-Gregori, andreu</dim:field>
5. <dim:field element="contributor" mdschema="dc" qualifier="author">Martinez-Selles, Manuel</dim:field>
6. <dim:field element="contributor" mdschema="dc" qualifier="author">Vazquez, Rafael</dim:field>
7. <dim:field element="contributor" mdschema="dc" qualifier="author">Gonzalez-Juanatey, Jose R.</dim:field>
8. <dim:field element="contributor" mdschema="dc" qualifier="author">Rivera, Miguel</dim:field>
9. <dim:field element="contributor" mdschema="dc" qualifier="author">Segovia, Javier</dim:field>
10. <dim:field element="contributor" mdschema="dc" qualifier="author">Pascual-Figal, Domingo</dim:field>
11. <dim:field element="contributor" mdschema="dc" qualifier="author">Bover, Ramon</dim:field>
12. <dim:field element="contributor" mdschema="dc" qualifier="author">Bascompte, Ramon</dim:field>
13. <dim:field element="contributor" mdschema="dc" qualifier="author">Delgado, Juan</dim:field>
14. <dim:field element="contributor" mdschema="dc" qualifier="author">Grau-Sepúlveda, Andrés</dim:field>
15. <dim:field element="contributor" mdschema="dc" qualifier="author">Bardaji, Alfredo</dim:field>
16. <dim:field element="contributor" mdschema="dc" qualifier="author">Perez-Villa, Felix</dim:field>
17. <dim:field element="contributor" mdschema="dc" qualifier="author">Zamorano, Jose Luis</dim:field>
18. <dim:field element="contributor" mdschema="dc" qualifier="author">Crespo-Leiro, Marisa</dim:field>
19. <dim:field element="contributor" mdschema="dc" qualifier="author">Sanchez, Pedro Luis</dim:field>
20. <dim:field element="contributor" mdschema="dc" qualifier="author">Ordonez-Llanos, Jordi</dim:field>
21. <dim:field element="contributor" mdschema="dc" qualifier="author">Cinca, Juan</dim:field>
22. <dim:field element="contributor" mdschema="dc" qualifier="author">Spanish Heart Failure Network</dim:field>
23. <dim:field element="date" mdschema="dc" qualifier="accessioned">2023-09-26T17:55:41Z</dim:field>
24. <dim:field element="date" mdschema="dc" qualifier="available">2023-09-26T17:55:41Z</dim:field>
25. <dim:field element="date" mdschema="dc" qualifier="issued">2021-10-22</dim:field>
26. <dim:field element="identifier" lang="en" mdschema="dc" qualifier="citation">alvarez-Garcia J, Garcia-Osuna A, Vives-Borras M, Ferrero-Gregori A, Martinez-Selles M, Vazquez R, et al. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Front Physiol. 2021 Oct 22;12:708890.</dim:field>
27. <dim:field element="identifier" mdschema="dc" qualifier="uri">https://hdl.handle.net/20.500.13003/19399</dim:field>
28. <dim:field element="identifier" mdschema="dc" qualifier="doi">10.3389/fphys.2021.708890</dim:field>
29. <dim:field element="identifier" mdschema="dc" qualifier="essn">1664-042X</dim:field>
30. <dim:field element="identifier" mdschema="dc" qualifier="pmid">34744758</dim:field>
31. <dim:field element="identifier" mdschema="dc" qualifier="pui">L636379719</dim:field>
32. <dim:field element="identifier" mdschema="dc" qualifier="scopus">2-s2.0-85118711903</dim:field>
33. <dim:field element="identifier" mdschema="dc" qualifier="wos">716498400001</dim:field>
34. <dim:field element="description" lang="en" mdschema="dc" qualifier="abstract">Introduction and Objectives: Most multi-biomarker strategies in acute heart failure (HF) have only measured biomarkers in a single-point time. This study aimed to evaluate the prognostic yielding of NT-proBNP, hsTnT, Cys-C, hs-CRP, GDF15, and GAL-3 in HF patients both at admission and discharge. Methods: We included 830 patients enrolled consecutively in a prospective multicenter registry. Primary outcome was 12-month mortality. The gain in the C-index, calibration, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) was calculated after adding each individual biomarker value or their combination on top of the best clinical model developed in this study (C-index 0.752, 0.715-0.789) and also on top of 4 currently used scores (MAGGIC, GWTG-HF, Redin-SCORE, BCN-bioHF). Results: After 12-month, death occurred in 154 (18.5%) cases. On top of the best clinical model, the addition of NT-proBNP, hs-CRP, and GDF-15 above the respective cutoff point at admission and discharge and their delta during compensation improved the C-index to 0.782 (0.747-0.817), IDI by 5% (p < 0.001), and NRI by 57% (p < 0.001) for 12-month mortality. A 4-risk grading categories for 12-month mortality (11.7, 19.2, 26.7, and 39.4%, respectively; p < 0.001) were obtained using combination of these biomarkers. Conclusion: A model including NT-proBNP, hs-CRP, and GDF-15 measured at admission and discharge afforded a mortality risk prediction greater than our clinical model and also better than the most currently used scores. In addition, this 3-biomarker panel defined 4-risk categories for 12-month mortality.</dim:field>
35. <dim:field element="description" lang="en" mdschema="dc" qualifier="fundingtext">This work was supported by grants from Redes Tematicas de Investigacion Cooperativa en Salud del Instituto de Salud Carlos III (REDINSCOR), Madrid, Spain (grant no. RD06-0003-0000) and Red de Investigacion Cardiovascular del Instituto de Salud Carlos III (RIC), Madrid, Spain (grant no. RD12/0042/0002).</dim:field>
36. <dim:field element="language" lang="en" mdschema="dc" qualifier="iso">eng</dim:field>
37. <dim:field element="publisher" lang="en" mdschema="dc">Frontiers Media Sa</dim:field>
38. <dim:field element="rights" lang="*" mdschema="dc">Attribution 4.0 International</dim:field>
39. <dim:field element="rights" lang="*" mdschema="dc" qualifier="uri">http://creativecommons.org/licenses/by/4.0/</dim:field>
40. <dim:field element="rights" lang="en" mdschema="dc" qualifier="accessRights">open access</dim:field>
41. <dim:field element="title" lang="en" mdschema="dc">A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure</dim:field>
42. <dim:field element="type" lang="en" mdschema="dc">research article</dim:field>
43. <dim:field element="journal" lang="en" mdschema="dc" qualifier="title">Frontiers in Physiology</dim:field>
44. <dim:field element="page" lang="en" mdschema="dc" qualifier="initial">708890</dim:field>
45. <dim:field element="subject" lang="en" mdschema="dc" qualifier="keyword">biomarker (BM)</dim:field>
46. <dim:field element="subject" lang="en" mdschema="dc" qualifier="keyword">panel (C33)</dim:field>
47. <dim:field element="subject" lang="en" mdschema="dc" qualifier="keyword">acute heart failure (AHF)</dim:field>
48. <dim:field element="subject" lang="en" mdschema="dc" qualifier="keyword">risk stratification</dim:field>
49. <dim:field element="subject" lang="en" mdschema="dc" qualifier="keyword">prognosis</dim:field>
50. <dim:field element="volume" lang="en" mdschema="dc" qualifier="number">12</dim:field>
51. <dim:field element="entity" mdschema="dspace" qualifier="type">Publication</dim:field>
</dim:dim>

etdms

Descarregar XML

<?xml version="1.0" encoding="UTF-8" ?>

<thesis schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.0/ http://www.ndltd.org/standards/metadata/etdms/1.0/etdms.xsd">
1. <title>A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure</title>
2. <creator>alvarez-Garcia, Jesus</creator>
3. <creator>Garcia-Osuna, Alvaro</creator>
4. <creator>Vives-Borrás, Miquel</creator>
5. <creator>Ferrero-Gregori, andreu</creator>
6. <creator>Martinez-Selles, Manuel</creator>
7. <creator>Vazquez, Rafael</creator>
8. <creator>Gonzalez-Juanatey, Jose R.</creator>
9. <creator>Rivera, Miguel</creator>
10. <creator>Segovia, Javier</creator>
11. <creator>Pascual-Figal, Domingo</creator>
12. <creator>Bover, Ramon</creator>
13. <creator>Bascompte, Ramon</creator>
14. <creator>Delgado, Juan</creator>
15. <creator>Grau-Sepúlveda, Andrés</creator>
16. <creator>Bardaji, Alfredo</creator>
17. <creator>Perez-Villa, Felix</creator>
18. <creator>Zamorano, Jose Luis</creator>
19. <creator>Crespo-Leiro, Marisa</creator>
20. <creator>Sanchez, Pedro Luis</creator>
21. <creator>Ordonez-Llanos, Jordi</creator>
22. <creator>Cinca, Juan</creator>
23. <creator>Spanish Heart Failure Network</creator>
24. <description>Introduction and Objectives: Most multi-biomarker strategies in acute heart failure (HF) have only measured biomarkers in a single-point time. This study aimed to evaluate the prognostic yielding of NT-proBNP, hsTnT, Cys-C, hs-CRP, GDF15, and GAL-3 in HF patients both at admission and discharge. Methods: We included 830 patients enrolled consecutively in a prospective multicenter registry. Primary outcome was 12-month mortality. The gain in the C-index, calibration, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) was calculated after adding each individual biomarker value or their combination on top of the best clinical model developed in this study (C-index 0.752, 0.715-0.789) and also on top of 4 currently used scores (MAGGIC, GWTG-HF, Redin-SCORE, BCN-bioHF). Results: After 12-month, death occurred in 154 (18.5%) cases. On top of the best clinical model, the addition of NT-proBNP, hs-CRP, and GDF-15 above the respective cutoff point at admission and discharge and their delta during compensation improved the C-index to 0.782 (0.747-0.817), IDI by 5% (p < 0.001), and NRI by 57% (p < 0.001) for 12-month mortality. A 4-risk grading categories for 12-month mortality (11.7, 19.2, 26.7, and 39.4%, respectively; p < 0.001) were obtained using combination of these biomarkers. Conclusion: A model including NT-proBNP, hs-CRP, and GDF-15 measured at admission and discharge afforded a mortality risk prediction greater than our clinical model and also better than the most currently used scores. In addition, this 3-biomarker panel defined 4-risk categories for 12-month mortality.</description>
25. <date>2023-09-26</date>
26. <date>2023-09-26</date>
27. <date>2021-10-22</date>
28. <type>research article</type>
29. <identifier>alvarez-Garcia J, Garcia-Osuna A, Vives-Borras M, Ferrero-Gregori A, Martinez-Selles M, Vazquez R, et al. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Front Physiol. 2021 Oct 22;12:708890.</identifier>
30. <identifier>https://hdl.handle.net/20.500.13003/19399</identifier>
31. <identifier>10.3389/fphys.2021.708890</identifier>
32. <identifier>1664-042X</identifier>
33. <identifier>34744758</identifier>
34. <identifier>L636379719</identifier>
35. <identifier>2-s2.0-85118711903</identifier>
36. <identifier>716498400001</identifier>
37. <language>eng</language>
38. <rights>http://creativecommons.org/licenses/by/4.0/</rights>
39. <rights>open access</rights>
40. <rights>Attribution 4.0 International</rights>
41. <publisher>Frontiers Media Sa</publisher>
</thesis>

marc

Descarregar XML

<?xml version="1.0" encoding="UTF-8" ?>

<record schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
1. <leader>00925njm 22002777a 4500</leader>
2. <datafield ind1=" " ind2=" " tag="042">
  1. <subfield code="a">dc</subfield>
  </datafield>
3. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">alvarez-Garcia, Jesus</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
4. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Garcia-Osuna, Alvaro</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
5. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Vives-Borrás, Miquel</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
6. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Ferrero-Gregori, andreu</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
7. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Martinez-Selles, Manuel</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
8. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Vazquez, Rafael</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
9. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Gonzalez-Juanatey, Jose R.</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
10. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Rivera, Miguel</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
11. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Segovia, Javier</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
12. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Pascual-Figal, Domingo</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
13. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Bover, Ramon</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
14. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Bascompte, Ramon</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
15. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Delgado, Juan</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
16. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Grau-Sepúlveda, Andrés</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
17. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Bardaji, Alfredo</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
18. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Perez-Villa, Felix</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
19. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Zamorano, Jose Luis</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
20. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Crespo-Leiro, Marisa</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
21. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Sanchez, Pedro Luis</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
22. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Ordonez-Llanos, Jordi</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
23. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Cinca, Juan</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
24. <datafield ind1=" " ind2=" " tag="720">
  1. <subfield code="a">Spanish Heart Failure Network</subfield>
  2. <subfield code="e">author</subfield>
  </datafield>
25. <datafield ind1=" " ind2=" " tag="260">
  1. <subfield code="c">2021-10-22</subfield>
  </datafield>
26. <datafield ind1=" " ind2=" " tag="520">
  1. <subfield code="a">Introduction and Objectives: Most multi-biomarker strategies in acute heart failure (HF) have only measured biomarkers in a single-point time. This study aimed to evaluate the prognostic yielding of NT-proBNP, hsTnT, Cys-C, hs-CRP, GDF15, and GAL-3 in HF patients both at admission and discharge. Methods: We included 830 patients enrolled consecutively in a prospective multicenter registry. Primary outcome was 12-month mortality. The gain in the C-index, calibration, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) was calculated after adding each individual biomarker value or their combination on top of the best clinical model developed in this study (C-index 0.752, 0.715-0.789) and also on top of 4 currently used scores (MAGGIC, GWTG-HF, Redin-SCORE, BCN-bioHF). Results: After 12-month, death occurred in 154 (18.5%) cases. On top of the best clinical model, the addition of NT-proBNP, hs-CRP, and GDF-15 above the respective cutoff point at admission and discharge and their delta during compensation improved the C-index to 0.782 (0.747-0.817), IDI by 5% (p < 0.001), and NRI by 57% (p < 0.001) for 12-month mortality. A 4-risk grading categories for 12-month mortality (11.7, 19.2, 26.7, and 39.4%, respectively; p < 0.001) were obtained using combination of these biomarkers. Conclusion: A model including NT-proBNP, hs-CRP, and GDF-15 measured at admission and discharge afforded a mortality risk prediction greater than our clinical model and also better than the most currently used scores. In addition, this 3-biomarker panel defined 4-risk categories for 12-month mortality.</subfield>
  </datafield>
27. <datafield ind1="8" ind2=" " tag="024">
  1. <subfield code="a">alvarez-Garcia J, Garcia-Osuna A, Vives-Borras M, Ferrero-Gregori A, Martinez-Selles M, Vazquez R, et al. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Front Physiol. 2021 Oct 22;12:708890.</subfield>
  </datafield>
28. <datafield ind1="8" ind2=" " tag="024">
  1. <subfield code="a">https://hdl.handle.net/20.500.13003/19399</subfield>
  </datafield>
29. <datafield ind1="8" ind2=" " tag="024">
  1. <subfield code="a">10.3389/fphys.2021.708890</subfield>
  </datafield>
30. <datafield ind1="8" ind2=" " tag="024">
  1. <subfield code="a">1664-042X</subfield>
  </datafield>
31. <datafield ind1="8" ind2=" " tag="024">
  1. <subfield code="a">34744758</subfield>
  </datafield>
32. <datafield ind1="8" ind2=" " tag="024">
  1. <subfield code="a">L636379719</subfield>
  </datafield>
33. <datafield ind1="8" ind2=" " tag="024">
  1. <subfield code="a">2-s2.0-85118711903</subfield>
  </datafield>
34. <datafield ind1="8" ind2=" " tag="024">
  1. <subfield code="a">716498400001</subfield>
  </datafield>
35. <datafield ind1="0" ind2="0" tag="245">
  1. <subfield code="a">A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure</subfield>
  </datafield>
</record>

mets

Descarregar XML

<?xml version="1.0" encoding="UTF-8" ?>

<mets ID=" DSpace_ITEM_20.500.13003-19399" OBJID=" hdl:20.500.13003/19399" PROFILE="DSpace METS SIP Profile 1.0" TYPE="DSpace ITEM" schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd">
1. <metsHdr CREATEDATE="2025-03-27T01:20:07Z">
  1. <agent ROLE="CUSTODIAN" TYPE="ORGANIZATION">
    1. <name>Docusalut</name>
    </agent>
  </metsHdr>
2. <dmdSec ID="DMD_20.500.13003_19399">
  1. <mdWrap MDTYPE="MODS">
    1. <xmlData schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
      1. <mods:mods schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>alvarez-Garcia, Jesus</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Garcia-Osuna, Alvaro</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Vives-Borrás, Miquel</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Ferrero-Gregori, andreu</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Martinez-Selles, Manuel</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Vazquez, Rafael</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Gonzalez-Juanatey, Jose R.</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Rivera, Miguel</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Segovia, Javier</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Pascual-Figal, Domingo</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Bover, Ramon</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Bascompte, Ramon</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Delgado, Juan</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Grau-Sepúlveda, Andrés</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Bardaji, Alfredo</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Perez-Villa, Felix</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Zamorano, Jose Luis</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Crespo-Leiro, Marisa</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Sanchez, Pedro Luis</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Ordonez-Llanos, Jordi</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Cinca, Juan</mods:namePart>
        </mods:name>
        <mods:name>
        <mods:role>
        <mods:roleTerm type="text">author</mods:roleTerm>
        </mods:role>
        <mods:namePart>Spanish Heart Failure Network</mods:namePart>
        </mods:name>
        <mods:extension>
        <mods:dateAccessioned encoding="iso8601">2023-09-26T17:55:41Z</mods:dateAccessioned>
        </mods:extension>
        <mods:extension>
        <mods:dateAvailable encoding="iso8601">2023-09-26T17:55:41Z</mods:dateAvailable>
        </mods:extension>
        <mods:originInfo>
        <mods:dateIssued encoding="iso8601">2021-10-22</mods:dateIssued>
        </mods:originInfo>
        <mods:identifier type="citation">alvarez-Garcia J, Garcia-Osuna A, Vives-Borras M, Ferrero-Gregori A, Martinez-Selles M, Vazquez R, et al. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Front Physiol. 2021 Oct 22;12:708890.</mods:identifier>
        <mods:identifier type="uri">https://hdl.handle.net/20.500.13003/19399</mods:identifier>
        <mods:identifier type="doi">10.3389/fphys.2021.708890</mods:identifier>
        <mods:identifier type="essn">1664-042X</mods:identifier>
        <mods:identifier type="pmid">34744758</mods:identifier>
        <mods:identifier type="pui">L636379719</mods:identifier>
        <mods:identifier type="scopus">2-s2.0-85118711903</mods:identifier>
        <mods:identifier type="wos">716498400001</mods:identifier>
        <mods:abstract>Introduction and Objectives: Most multi-biomarker strategies in acute heart failure (HF) have only measured biomarkers in a single-point time. This study aimed to evaluate the prognostic yielding of NT-proBNP, hsTnT, Cys-C, hs-CRP, GDF15, and GAL-3 in HF patients both at admission and discharge. Methods: We included 830 patients enrolled consecutively in a prospective multicenter registry. Primary outcome was 12-month mortality. The gain in the C-index, calibration, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) was calculated after adding each individual biomarker value or their combination on top of the best clinical model developed in this study (C-index 0.752, 0.715-0.789) and also on top of 4 currently used scores (MAGGIC, GWTG-HF, Redin-SCORE, BCN-bioHF). Results: After 12-month, death occurred in 154 (18.5%) cases. On top of the best clinical model, the addition of NT-proBNP, hs-CRP, and GDF-15 above the respective cutoff point at admission and discharge and their delta during compensation improved the C-index to 0.782 (0.747-0.817), IDI by 5% (p < 0.001), and NRI by 57% (p < 0.001) for 12-month mortality. A 4-risk grading categories for 12-month mortality (11.7, 19.2, 26.7, and 39.4%, respectively; p < 0.001) were obtained using combination of these biomarkers. Conclusion: A model including NT-proBNP, hs-CRP, and GDF-15 measured at admission and discharge afforded a mortality risk prediction greater than our clinical model and also better than the most currently used scores. In addition, this 3-biomarker panel defined 4-risk categories for 12-month mortality.</mods:abstract>
        <mods:language>
        <mods:languageTerm authority="rfc3066">eng</mods:languageTerm>
        </mods:language>
        <mods:accessCondition type="useAndReproduction">Attribution 4.0 International</mods:accessCondition>
        <mods:titleInfo>
        <mods:title>A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure</mods:title>
        </mods:titleInfo>
        <mods:genre>research article</mods:genre>
        </mods:mods>
      </xmlData>
    </mdWrap>
  </dmdSec>
3. <amdSec ID="FO_20.500.13003_19399_1">
  1. <techMD ID="TECH_O_20.500.13003_19399_1">
    1. <mdWrap MDTYPE="PREMIS">
      1. <xmlData schemaLocation="http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd">
        <premis:premis>
        <premis:object>
        <premis:objectIdentifier>
        <premis:objectIdentifierType>URL</premis:objectIdentifierType>
        <premis:objectIdentifierValue>https://docusalut.com/bitstreams/5a8b84b1-6ed7-4c7d-845e-d7ffd3ff8292/download</premis:objectIdentifierValue>
        </premis:objectIdentifier>
        <premis:objectCategory>File</premis:objectCategory>
        <premis:objectCharacteristics>
        <premis:fixity>
        <premis:messageDigestAlgorithm>MD5</premis:messageDigestAlgorithm>
        <premis:messageDigest>dd52ce0c8d068ffdbb95d4240d4cf702</premis:messageDigest>
        </premis:fixity>
        <premis:size>442293</premis:size>
        <premis:format>
        <premis:formatDesignation>
        <premis:formatName>application/pdf</premis:formatName>
        </premis:formatDesignation>
        </premis:format>
        </premis:objectCharacteristics>
        <premis:originalName>000716498400001.pdf</premis:originalName>
        </premis:object>
        </premis:premis>
        </xmlData>
      </mdWrap>
    </techMD>
  </amdSec>
4. <amdSec ID="FT_20.500.13003_19399_3">
  1. <techMD ID="TECH_T_20.500.13003_19399_3">
    1. <mdWrap MDTYPE="PREMIS">
      1. <xmlData schemaLocation="http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd">
        <premis:premis>
        <premis:object>
        <premis:objectIdentifier>
        <premis:objectIdentifierType>URL</premis:objectIdentifierType>
        <premis:objectIdentifierValue>https://docusalut.com/bitstreams/f8f7760f-7952-4cad-9b19-1de6567d4371/download</premis:objectIdentifierValue>
        </premis:objectIdentifier>
        <premis:objectCategory>File</premis:objectCategory>
        <premis:objectCharacteristics>
        <premis:fixity>
        <premis:messageDigestAlgorithm>MD5</premis:messageDigestAlgorithm>
        <premis:messageDigest>170a1dfefd8bd0580228e0a3601893f2</premis:messageDigest>
        </premis:fixity>
        <premis:size>46471</premis:size>
        <premis:format>
        <premis:formatDesignation>
        <premis:formatName>text/plain</premis:formatName>
        </premis:formatDesignation>
        </premis:format>
        </premis:objectCharacteristics>
        <premis:originalName>000716498400001.pdf.txt</premis:originalName>
        </premis:object>
        </premis:premis>
        </xmlData>
      </mdWrap>
    </techMD>
  </amdSec>
5. <fileSec>
  1. <fileGrp USE="ORIGINAL">
    1. <file ADMID="FO_20.500.13003_19399_1" CHECKSUM="dd52ce0c8d068ffdbb95d4240d4cf702" CHECKSUMTYPE="MD5" GROUPID="GROUP_BITSTREAM_20.500.13003_19399_1" ID="BITSTREAM_ORIGINAL_20.500.13003_19399_1" MIMETYPE="application/pdf" SEQ="1" SIZE="442293">
      1. <FLocat LOCTYPE="URL" href="https://docusalut.com/bitstreams/5a8b84b1-6ed7-4c7d-845e-d7ffd3ff8292/download" type="simple" />
      </file>
    </fileGrp>
  2. <fileGrp USE="TEXT">
    1. <file ADMID="FT_20.500.13003_19399_3" CHECKSUM="170a1dfefd8bd0580228e0a3601893f2" CHECKSUMTYPE="MD5" GROUPID="GROUP_BITSTREAM_20.500.13003_19399_3" ID="BITSTREAM_TEXT_20.500.13003_19399_3" MIMETYPE="text/plain" SEQ="3" SIZE="46471">
      1. <FLocat LOCTYPE="URL" href="https://docusalut.com/bitstreams/f8f7760f-7952-4cad-9b19-1de6567d4371/download" type="simple" />
      </file>
    </fileGrp>
  </fileSec>
6. <structMap LABEL="DSpace Object" TYPE="LOGICAL">
  1. <div ADMID="DMD_20.500.13003_19399" TYPE="DSpace Object Contents">
    1. <div TYPE="DSpace BITSTREAM">
      1. <fptr FILEID="BITSTREAM_ORIGINAL_20.500.13003_19399_1" />
      </div>
    </div>
  </structMap>
</mets>

mods

Descarregar XML

<?xml version="1.0" encoding="UTF-8" ?>

<mods:mods schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
1. <mods:name>
  1. <mods:namePart>alvarez-Garcia, Jesus</mods:namePart>
  </mods:name>
2. <mods:name>
  1. <mods:namePart>Garcia-Osuna, Alvaro</mods:namePart>
  </mods:name>
3. <mods:name>
  1. <mods:namePart>Vives-Borrás, Miquel</mods:namePart>
  </mods:name>
4. <mods:name>
  1. <mods:namePart>Ferrero-Gregori, andreu</mods:namePart>
  </mods:name>
5. <mods:name>
  1. <mods:namePart>Martinez-Selles, Manuel</mods:namePart>
  </mods:name>
6. <mods:name>
  1. <mods:namePart>Vazquez, Rafael</mods:namePart>
  </mods:name>
7. <mods:name>
  1. <mods:namePart>Gonzalez-Juanatey, Jose R.</mods:namePart>
  </mods:name>
8. <mods:name>
  1. <mods:namePart>Rivera, Miguel</mods:namePart>
  </mods:name>
9. <mods:name>
  1. <mods:namePart>Segovia, Javier</mods:namePart>
  </mods:name>
10. <mods:name>
  1. <mods:namePart>Pascual-Figal, Domingo</mods:namePart>
  </mods:name>
11. <mods:name>
  1. <mods:namePart>Bover, Ramon</mods:namePart>
  </mods:name>
12. <mods:name>
  1. <mods:namePart>Bascompte, Ramon</mods:namePart>
  </mods:name>
13. <mods:name>
  1. <mods:namePart>Delgado, Juan</mods:namePart>
  </mods:name>
14. <mods:name>
  1. <mods:namePart>Grau-Sepúlveda, Andrés</mods:namePart>
  </mods:name>
15. <mods:name>
  1. <mods:namePart>Bardaji, Alfredo</mods:namePart>
  </mods:name>
16. <mods:name>
  1. <mods:namePart>Perez-Villa, Felix</mods:namePart>
  </mods:name>
17. <mods:name>
  1. <mods:namePart>Zamorano, Jose Luis</mods:namePart>
  </mods:name>
18. <mods:name>
  1. <mods:namePart>Crespo-Leiro, Marisa</mods:namePart>
  </mods:name>
19. <mods:name>
  1. <mods:namePart>Sanchez, Pedro Luis</mods:namePart>
  </mods:name>
20. <mods:name>
  1. <mods:namePart>Ordonez-Llanos, Jordi</mods:namePart>
  </mods:name>
21. <mods:name>
  1. <mods:namePart>Cinca, Juan</mods:namePart>
  </mods:name>
22. <mods:name>
  1. <mods:namePart>Spanish Heart Failure Network</mods:namePart>
  </mods:name>
23. <mods:extension>
  1. <mods:dateAvailable encoding="iso8601">2023-09-26T17:55:41Z</mods:dateAvailable>
  </mods:extension>
24. <mods:extension>
  1. <mods:dateAccessioned encoding="iso8601">2023-09-26T17:55:41Z</mods:dateAccessioned>
  </mods:extension>
25. <mods:originInfo>
  1. <mods:dateIssued encoding="iso8601">2021-10-22</mods:dateIssued>
  </mods:originInfo>
26. <mods:identifier type="citation">alvarez-Garcia J, Garcia-Osuna A, Vives-Borras M, Ferrero-Gregori A, Martinez-Selles M, Vazquez R, et al. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Front Physiol. 2021 Oct 22;12:708890.</mods:identifier>
27. <mods:identifier type="uri">https://hdl.handle.net/20.500.13003/19399</mods:identifier>
28. <mods:identifier type="doi">10.3389/fphys.2021.708890</mods:identifier>
29. <mods:identifier type="essn">1664-042X</mods:identifier>
30. <mods:identifier type="pmid">34744758</mods:identifier>
31. <mods:identifier type="pui">L636379719</mods:identifier>
32. <mods:identifier type="scopus">2-s2.0-85118711903</mods:identifier>
33. <mods:identifier type="wos">716498400001</mods:identifier>
34. <mods:abstract>Introduction and Objectives: Most multi-biomarker strategies in acute heart failure (HF) have only measured biomarkers in a single-point time. This study aimed to evaluate the prognostic yielding of NT-proBNP, hsTnT, Cys-C, hs-CRP, GDF15, and GAL-3 in HF patients both at admission and discharge. Methods: We included 830 patients enrolled consecutively in a prospective multicenter registry. Primary outcome was 12-month mortality. The gain in the C-index, calibration, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) was calculated after adding each individual biomarker value or their combination on top of the best clinical model developed in this study (C-index 0.752, 0.715-0.789) and also on top of 4 currently used scores (MAGGIC, GWTG-HF, Redin-SCORE, BCN-bioHF). Results: After 12-month, death occurred in 154 (18.5%) cases. On top of the best clinical model, the addition of NT-proBNP, hs-CRP, and GDF-15 above the respective cutoff point at admission and discharge and their delta during compensation improved the C-index to 0.782 (0.747-0.817), IDI by 5% (p < 0.001), and NRI by 57% (p < 0.001) for 12-month mortality. A 4-risk grading categories for 12-month mortality (11.7, 19.2, 26.7, and 39.4%, respectively; p < 0.001) were obtained using combination of these biomarkers. Conclusion: A model including NT-proBNP, hs-CRP, and GDF-15 measured at admission and discharge afforded a mortality risk prediction greater than our clinical model and also better than the most currently used scores. In addition, this 3-biomarker panel defined 4-risk categories for 12-month mortality.</mods:abstract>
35. <mods:language>
  1. <mods:languageTerm>eng</mods:languageTerm>
  </mods:language>
36. <mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by/4.0/</mods:accessCondition>
37. <mods:accessCondition type="useAndReproduction">open access</mods:accessCondition>
38. <mods:accessCondition type="useAndReproduction">Attribution 4.0 International</mods:accessCondition>
39. <mods:titleInfo>
  1. <mods:title>A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure</mods:title>
  </mods:titleInfo>
40. <mods:genre>research article</mods:genre>
</mods:mods>

ore

Descarregar XML

<?xml version="1.0" encoding="UTF-8" ?>

<atom:entry schemaLocation="http://www.w3.org/2005/Atom http://www.kbcafe.com/rss/atom.xsd.xml">
1. <atom:id>https://hdl.handle.net/20.500.13003/19399/ore.xml</atom:id>
2. <atom:link href="https://hdl.handle.net/20.500.13003/19399" rel="alternate" />
3. <atom:link href="https://hdl.handle.net/20.500.13003/19399/ore.xml" rel="http://www.openarchives.org/ore/terms/describes" />
4. <atom:link href="https://hdl.handle.net/20.500.13003/19399/ore.xml#atom" rel="self" type="application/atom+xml" />
5. <atom:published>2023-09-26T17:55:41Z</atom:published>
6. <atom:updated>2023-09-26T17:55:41Z</atom:updated>
7. <atom:source>
  1. <atom:generator>Docusalut</atom:generator>
  </atom:source>
8. <atom:title>A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure</atom:title>
9. <atom:author>
  1. <atom:name>alvarez-Garcia, Jesus</atom:name>
  </atom:author>
10. <atom:author>
  1. <atom:name>Garcia-Osuna, Alvaro</atom:name>
  </atom:author>
11. <atom:author>
  1. <atom:name>Vives-Borrás, Miquel</atom:name>
  </atom:author>
12. <atom:author>
  1. <atom:name>Ferrero-Gregori, andreu</atom:name>
  </atom:author>
13. <atom:author>
  1. <atom:name>Martinez-Selles, Manuel</atom:name>
  </atom:author>
14. <atom:author>
  1. <atom:name>Vazquez, Rafael</atom:name>
  </atom:author>
15. <atom:author>
  1. <atom:name>Gonzalez-Juanatey, Jose R.</atom:name>
  </atom:author>
16. <atom:author>
  1. <atom:name>Rivera, Miguel</atom:name>
  </atom:author>
17. <atom:author>
  1. <atom:name>Segovia, Javier</atom:name>
  </atom:author>
18. <atom:author>
  1. <atom:name>Pascual-Figal, Domingo</atom:name>
  </atom:author>
19. <atom:author>
  1. <atom:name>Bover, Ramon</atom:name>
  </atom:author>
20. <atom:author>
  1. <atom:name>Bascompte, Ramon</atom:name>
  </atom:author>
21. <atom:author>
  1. <atom:name>Delgado, Juan</atom:name>
  </atom:author>
22. <atom:author>
  1. <atom:name>Grau-Sepúlveda, Andrés</atom:name>
  </atom:author>
23. <atom:author>
  1. <atom:name>Bardaji, Alfredo</atom:name>
  </atom:author>
24. <atom:author>
  1. <atom:name>Perez-Villa, Felix</atom:name>
  </atom:author>
25. <atom:author>
  1. <atom:name>Zamorano, Jose Luis</atom:name>
  </atom:author>
26. <atom:author>
  1. <atom:name>Crespo-Leiro, Marisa</atom:name>
  </atom:author>
27. <atom:author>
  1. <atom:name>Sanchez, Pedro Luis</atom:name>
  </atom:author>
28. <atom:author>
  1. <atom:name>Ordonez-Llanos, Jordi</atom:name>
  </atom:author>
29. <atom:author>
  1. <atom:name>Cinca, Juan</atom:name>
  </atom:author>
30. <atom:author>
  1. <atom:name>Spanish Heart Failure Network</atom:name>
  </atom:author>
31. <atom:category label="Aggregation" scheme="http://www.openarchives.org/ore/terms/" term="http://www.openarchives.org/ore/terms/Aggregation" />
32. <atom:category scheme="http://www.openarchives.org/ore/atom/modified" term="2023-09-26T17:55:41Z" />
33. <atom:category label="DSpace Item" scheme="http://www.dspace.org/objectModel/" term="DSpaceItem" />
34. <atom:link href="https://docusalut.com/bitstreams/5a8b84b1-6ed7-4c7d-845e-d7ffd3ff8292/download" length="442293" rel="http://www.openarchives.org/ore/terms/aggregates" title="000716498400001.pdf" type="application/pdf" />
35. <oreatom:triples>
  1. <rdf:Description about="https://hdl.handle.net/20.500.13003/19399/ore.xml#atom">
    1. <rdf:type resource="http://www.dspace.org/objectModel/DSpaceItem" />
    2. <dcterms:modified>2023-09-26T17:55:41Z</dcterms:modified>
    </rdf:Description>
  2. <rdf:Description about="https://docusalut.com/bitstreams/5a8b84b1-6ed7-4c7d-845e-d7ffd3ff8292/download">
    1. <rdf:type resource="http://www.dspace.org/objectModel/DSpaceBitstream" />
    2. <dcterms:description>ORIGINAL</dcterms:description>
    </rdf:Description>
  3. <rdf:Description about="https://docusalut.com/bitstreams/7218d6db-0132-4832-a311-e780c5a03a4c/download">
    1. <rdf:type resource="http://www.dspace.org/objectModel/DSpaceBitstream" />
    2. <dcterms:description>CC-LICENSE</dcterms:description>
    </rdf:Description>
  4. <rdf:Description about="https://docusalut.com/bitstreams/f8f7760f-7952-4cad-9b19-1de6567d4371/download">
    1. <rdf:type resource="http://www.dspace.org/objectModel/DSpaceBitstream" />
    2. <dcterms:description>TEXT</dcterms:description>
    </rdf:Description>
  5. <rdf:Description about="https://docusalut.com/bitstreams/2126acd2-5152-4340-b623-8a679b6d3ef8/download">
    1. <rdf:type resource="http://www.dspace.org/objectModel/DSpaceBitstream" />
    2. <dcterms:description>THUMBNAIL</dcterms:description>
    </rdf:Description>
  </oreatom:triples>
</atom:entry>

qdc

Descarregar XML

<?xml version="1.0" encoding="UTF-8" ?>

<qdc:qualifieddc schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
1. <dc:title>A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure</dc:title>
2. <dc:creator>alvarez-Garcia, Jesus</dc:creator>
3. <dc:creator>Garcia-Osuna, Alvaro</dc:creator>
4. <dc:creator>Vives-Borrás, Miquel</dc:creator>
5. <dc:creator>Ferrero-Gregori, andreu</dc:creator>
6. <dc:creator>Martinez-Selles, Manuel</dc:creator>
7. <dc:creator>Vazquez, Rafael</dc:creator>
8. <dc:creator>Gonzalez-Juanatey, Jose R.</dc:creator>
9. <dc:creator>Rivera, Miguel</dc:creator>
10. <dc:creator>Segovia, Javier</dc:creator>
11. <dc:creator>Pascual-Figal, Domingo</dc:creator>
12. <dc:creator>Bover, Ramon</dc:creator>
13. <dc:creator>Bascompte, Ramon</dc:creator>
14. <dc:creator>Delgado, Juan</dc:creator>
15. <dc:creator>Grau-Sepúlveda, Andrés</dc:creator>
16. <dc:creator>Bardaji, Alfredo</dc:creator>
17. <dc:creator>Perez-Villa, Felix</dc:creator>
18. <dc:creator>Zamorano, Jose Luis</dc:creator>
19. <dc:creator>Crespo-Leiro, Marisa</dc:creator>
20. <dc:creator>Sanchez, Pedro Luis</dc:creator>
21. <dc:creator>Ordonez-Llanos, Jordi</dc:creator>
22. <dc:creator>Cinca, Juan</dc:creator>
23. <dc:creator>Spanish Heart Failure Network</dc:creator>
24. <dcterms:abstract>Introduction and Objectives: Most multi-biomarker strategies in acute heart failure (HF) have only measured biomarkers in a single-point time. This study aimed to evaluate the prognostic yielding of NT-proBNP, hsTnT, Cys-C, hs-CRP, GDF15, and GAL-3 in HF patients both at admission and discharge. Methods: We included 830 patients enrolled consecutively in a prospective multicenter registry. Primary outcome was 12-month mortality. The gain in the C-index, calibration, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) was calculated after adding each individual biomarker value or their combination on top of the best clinical model developed in this study (C-index 0.752, 0.715-0.789) and also on top of 4 currently used scores (MAGGIC, GWTG-HF, Redin-SCORE, BCN-bioHF). Results: After 12-month, death occurred in 154 (18.5%) cases. On top of the best clinical model, the addition of NT-proBNP, hs-CRP, and GDF-15 above the respective cutoff point at admission and discharge and their delta during compensation improved the C-index to 0.782 (0.747-0.817), IDI by 5% (p < 0.001), and NRI by 57% (p < 0.001) for 12-month mortality. A 4-risk grading categories for 12-month mortality (11.7, 19.2, 26.7, and 39.4%, respectively; p < 0.001) were obtained using combination of these biomarkers. Conclusion: A model including NT-proBNP, hs-CRP, and GDF-15 measured at admission and discharge afforded a mortality risk prediction greater than our clinical model and also better than the most currently used scores. In addition, this 3-biomarker panel defined 4-risk categories for 12-month mortality.</dcterms:abstract>
25. <dcterms:dateAccepted>2023-09-26T17:55:41Z</dcterms:dateAccepted>
26. <dcterms:available>2023-09-26T17:55:41Z</dcterms:available>
27. <dcterms:created>2023-09-26T17:55:41Z</dcterms:created>
28. <dcterms:issued>2021-10-22</dcterms:issued>
29. <dc:type>research article</dc:type>
30. <dc:identifier>alvarez-Garcia J, Garcia-Osuna A, Vives-Borras M, Ferrero-Gregori A, Martinez-Selles M, Vazquez R, et al. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Front Physiol. 2021 Oct 22;12:708890.</dc:identifier>
31. <dc:identifier>https://hdl.handle.net/20.500.13003/19399</dc:identifier>
32. <dc:identifier>10.3389/fphys.2021.708890</dc:identifier>
33. <dc:identifier>1664-042X</dc:identifier>
34. <dc:identifier>34744758</dc:identifier>
35. <dc:identifier>L636379719</dc:identifier>
36. <dc:identifier>2-s2.0-85118711903</dc:identifier>
37. <dc:identifier>716498400001</dc:identifier>
38. <dc:language>eng</dc:language>
39. <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
40. <dc:rights>open access</dc:rights>
41. <dc:rights>Attribution 4.0 International</dc:rights>
42. <dc:publisher>Frontiers Media Sa</dc:publisher>
</qdc:qualifieddc>

rdf

Descarregar XML

<?xml version="1.0" encoding="UTF-8" ?>

<rdf:RDF schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
1. <ow:Publication about="oai:docusalut.com:20.500.13003/19399">
  1. <dc:title>A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure</dc:title>
  2. <dc:creator>alvarez-Garcia, Jesus</dc:creator>
  3. <dc:creator>Garcia-Osuna, Alvaro</dc:creator>
  4. <dc:creator>Vives-Borrás, Miquel</dc:creator>
  5. <dc:creator>Ferrero-Gregori, andreu</dc:creator>
  6. <dc:creator>Martinez-Selles, Manuel</dc:creator>
  7. <dc:creator>Vazquez, Rafael</dc:creator>
  8. <dc:creator>Gonzalez-Juanatey, Jose R.</dc:creator>
  9. <dc:creator>Rivera, Miguel</dc:creator>
  10. <dc:creator>Segovia, Javier</dc:creator>
  11. <dc:creator>Pascual-Figal, Domingo</dc:creator>
  12. <dc:creator>Bover, Ramon</dc:creator>
  13. <dc:creator>Bascompte, Ramon</dc:creator>
  14. <dc:creator>Delgado, Juan</dc:creator>
  15. <dc:creator>Grau-Sepúlveda, Andrés</dc:creator>
  16. <dc:creator>Bardaji, Alfredo</dc:creator>
  17. <dc:creator>Perez-Villa, Felix</dc:creator>
  18. <dc:creator>Zamorano, Jose Luis</dc:creator>
  19. <dc:creator>Crespo-Leiro, Marisa</dc:creator>
  20. <dc:creator>Sanchez, Pedro Luis</dc:creator>
  21. <dc:creator>Ordonez-Llanos, Jordi</dc:creator>
  22. <dc:creator>Cinca, Juan</dc:creator>
  23. <dc:creator>Spanish Heart Failure Network</dc:creator>
  24. <dc:description>Introduction and Objectives: Most multi-biomarker strategies in acute heart failure (HF) have only measured biomarkers in a single-point time. This study aimed to evaluate the prognostic yielding of NT-proBNP, hsTnT, Cys-C, hs-CRP, GDF15, and GAL-3 in HF patients both at admission and discharge. Methods: We included 830 patients enrolled consecutively in a prospective multicenter registry. Primary outcome was 12-month mortality. The gain in the C-index, calibration, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) was calculated after adding each individual biomarker value or their combination on top of the best clinical model developed in this study (C-index 0.752, 0.715-0.789) and also on top of 4 currently used scores (MAGGIC, GWTG-HF, Redin-SCORE, BCN-bioHF). Results: After 12-month, death occurred in 154 (18.5%) cases. On top of the best clinical model, the addition of NT-proBNP, hs-CRP, and GDF-15 above the respective cutoff point at admission and discharge and their delta during compensation improved the C-index to 0.782 (0.747-0.817), IDI by 5% (p < 0.001), and NRI by 57% (p < 0.001) for 12-month mortality. A 4-risk grading categories for 12-month mortality (11.7, 19.2, 26.7, and 39.4%, respectively; p < 0.001) were obtained using combination of these biomarkers. Conclusion: A model including NT-proBNP, hs-CRP, and GDF-15 measured at admission and discharge afforded a mortality risk prediction greater than our clinical model and also better than the most currently used scores. In addition, this 3-biomarker panel defined 4-risk categories for 12-month mortality.</dc:description>
  25. <dc:date>2023-09-26T17:55:41Z</dc:date>
  26. <dc:date>2023-09-26T17:55:41Z</dc:date>
  27. <dc:date>2021-10-22</dc:date>
  28. <dc:type>research article</dc:type>
  29. <dc:identifier>alvarez-Garcia J, Garcia-Osuna A, Vives-Borras M, Ferrero-Gregori A, Martinez-Selles M, Vazquez R, et al. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Front Physiol. 2021 Oct 22;12:708890.</dc:identifier>
  30. <dc:identifier>https://hdl.handle.net/20.500.13003/19399</dc:identifier>
  31. <dc:identifier>10.3389/fphys.2021.708890</dc:identifier>
  32. <dc:identifier>1664-042X</dc:identifier>
  33. <dc:identifier>34744758</dc:identifier>
  34. <dc:identifier>L636379719</dc:identifier>
  35. <dc:identifier>2-s2.0-85118711903</dc:identifier>
  36. <dc:identifier>716498400001</dc:identifier>
  37. <dc:language>eng</dc:language>
  38. <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
  39. <dc:rights>open access</dc:rights>
  40. <dc:rights>Attribution 4.0 International</dc:rights>
  41. <dc:publisher>Frontiers Media Sa</dc:publisher>
  </ow:Publication>
</rdf:RDF>

xoai

Descarregar XML

<?xml version="1.0" encoding="UTF-8" ?>

<metadata schemaLocation="http://www.lyncode.com/xoai http://www.lyncode.com/xsd/xoai.xsd">
1. <element name="dc">
  1. <element name="contributor">
    1. <element name="author">
      1. <element name="none">
        <field name="value">alvarez-Garcia, Jesus</field>
        <field name="value">Garcia-Osuna, Alvaro</field>
        <field name="value">Vives-Borrás, Miquel</field>
        <field name="value">Ferrero-Gregori, andreu</field>
        <field name="value">Martinez-Selles, Manuel</field>
        <field name="value">Vazquez, Rafael</field>
        <field name="value">Gonzalez-Juanatey, Jose R.</field>
        <field name="value">Rivera, Miguel</field>
        <field name="value">Segovia, Javier</field>
        <field name="value">Pascual-Figal, Domingo</field>
        <field name="value">Bover, Ramon</field>
        <field name="value">Bascompte, Ramon</field>
        <field name="value">Delgado, Juan</field>
        <field name="value">Grau-Sepúlveda, Andrés</field>
        <field name="value">Bardaji, Alfredo</field>
        <field name="value">Perez-Villa, Felix</field>
        <field name="value">Zamorano, Jose Luis</field>
        <field name="value">Crespo-Leiro, Marisa</field>
        <field name="value">Sanchez, Pedro Luis</field>
        <field name="value">Ordonez-Llanos, Jordi</field>
        <field name="value">Cinca, Juan</field>
        <field name="value">Spanish Heart Failure Network</field>
        </element>
      </element>
    </element>
  2. <element name="date">
    1. <element name="accessioned">
      1. <element name="none">
        <field name="value">2023-09-26T17:55:41Z</field>
        </element>
      </element>
    2. <element name="available">
      1. <element name="none">
        <field name="value">2023-09-26T17:55:41Z</field>
        </element>
      </element>
    3. <element name="issued">
      1. <element name="none">
        <field name="value">2021-10-22</field>
        </element>
      </element>
    </element>
  3. <element name="identifier">
    1. <element name="citation">
      1. <element name="en">
        <field name="value">alvarez-Garcia J, Garcia-Osuna A, Vives-Borras M, Ferrero-Gregori A, Martinez-Selles M, Vazquez R, et al. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Front Physiol. 2021 Oct 22;12:708890.</field>
        </element>
      </element>
    2. <element name="uri">
      1. <element name="none">
        <field name="value">https://hdl.handle.net/20.500.13003/19399</field>
        </element>
      </element>
    3. <element name="doi">
      1. <element name="none">
        <field name="value">10.3389/fphys.2021.708890</field>
        </element>
      </element>
    4. <element name="essn">
      1. <element name="none">
        <field name="value">1664-042X</field>
        </element>
      </element>
    5. <element name="pmid">
      1. <element name="none">
        <field name="value">34744758</field>
        </element>
      </element>
    6. <element name="pui">
      1. <element name="none">
        <field name="value">L636379719</field>
        </element>
      </element>
    7. <element name="scopus">
      1. <element name="none">
        <field name="value">2-s2.0-85118711903</field>
        </element>
      </element>
    8. <element name="wos">
      1. <element name="none">
        <field name="value">716498400001</field>
        </element>
      </element>
    </element>
  4. <element name="description">
    1. <element name="abstract">
      1. <element name="en">
        <field name="value">Introduction and Objectives: Most multi-biomarker strategies in acute heart failure (HF) have only measured biomarkers in a single-point time. This study aimed to evaluate the prognostic yielding of NT-proBNP, hsTnT, Cys-C, hs-CRP, GDF15, and GAL-3 in HF patients both at admission and discharge. Methods: We included 830 patients enrolled consecutively in a prospective multicenter registry. Primary outcome was 12-month mortality. The gain in the C-index, calibration, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) was calculated after adding each individual biomarker value or their combination on top of the best clinical model developed in this study (C-index 0.752, 0.715-0.789) and also on top of 4 currently used scores (MAGGIC, GWTG-HF, Redin-SCORE, BCN-bioHF). Results: After 12-month, death occurred in 154 (18.5%) cases. On top of the best clinical model, the addition of NT-proBNP, hs-CRP, and GDF-15 above the respective cutoff point at admission and discharge and their delta during compensation improved the C-index to 0.782 (0.747-0.817), IDI by 5% (p < 0.001), and NRI by 57% (p < 0.001) for 12-month mortality. A 4-risk grading categories for 12-month mortality (11.7, 19.2, 26.7, and 39.4%, respectively; p < 0.001) were obtained using combination of these biomarkers. Conclusion: A model including NT-proBNP, hs-CRP, and GDF-15 measured at admission and discharge afforded a mortality risk prediction greater than our clinical model and also better than the most currently used scores. In addition, this 3-biomarker panel defined 4-risk categories for 12-month mortality.</field>
        </element>
      </element>
    2. <element name="fundingtext">
      1. <element name="en">
        <field name="value">This work was supported by grants from Redes Tematicas de Investigacion Cooperativa en Salud del Instituto de Salud Carlos III (REDINSCOR), Madrid, Spain (grant no. RD06-0003-0000) and Red de Investigacion Cardiovascular del Instituto de Salud Carlos III (RIC), Madrid, Spain (grant no. RD12/0042/0002).</field>
        </element>
      </element>
    </element>
  5. <element name="language">
    1. <element name="iso">
      1. <element name="en">
        <field name="value">eng</field>
        </element>
      </element>
    </element>
  6. <element name="publisher">
    1. <element name="en">
      1. <field name="value">Frontiers Media Sa</field>
      </element>
    </element>
  7. <element name="rights">
    1. <element name="*">
      1. <field name="value">Attribution 4.0 International</field>
      </element>
    2. <element name="uri">
      1. <element name="*">
        <field name="value">http://creativecommons.org/licenses/by/4.0/</field>
        </element>
      </element>
    3. <element name="accessRights">
      1. <element name="en">
        <field name="value">open access</field>
        </element>
      </element>
    </element>
  8. <element name="title">
    1. <element name="en">
      1. <field name="value">A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure</field>
      </element>
    </element>
  9. <element name="type">
    1. <element name="en">
      1. <field name="value">research article</field>
      </element>
    </element>
  10. <element name="journal">
    1. <element name="title">
      1. <element name="en">
        <field name="value">Frontiers in Physiology</field>
        </element>
      </element>
    </element>
  11. <element name="page">
    1. <element name="initial">
      1. <element name="en">
        <field name="value">708890</field>
        </element>
      </element>
    </element>
  12. <element name="subject">
    1. <element name="keyword">
      1. <element name="en">
        <field name="value">biomarker (BM)</field>
        <field name="value">panel (C33)</field>
        <field name="value">acute heart failure (AHF)</field>
        <field name="value">risk stratification</field>
        <field name="value">prognosis</field>
        </element>
      </element>
    </element>
  13. <element name="volume">
    1. <element name="number">
      1. <element name="en">
        <field name="value">12</field>
        </element>
      </element>
    </element>
  </element>
2. <element name="dspace">
  1. <element name="entity">
    1. <element name="type">
      1. <element name="none">
        <field name="value">Publication</field>
        </element>
      </element>
    </element>
  </element>
3. <element name="bundles">
  1. <element name="bundle">
    1. <field name="name">ORIGINAL</field>
    2. <element name="bitstreams">
      1. <element name="bitstream">
        <field name="name">000716498400001.pdf</field>
        <field name="format">application/pdf</field>
        <field name="size">442293</field>
        <field name="url">https://docusalut.com/bitstreams/5a8b84b1-6ed7-4c7d-845e-d7ffd3ff8292/download</field>
        <field name="checksum">dd52ce0c8d068ffdbb95d4240d4cf702</field>
        <field name="checksumAlgorithm">MD5</field>
        <field name="sid">1</field>
        </element>
      </element>
    </element>
  2. <element name="bundle">
    1. <field name="name">CC-LICENSE</field>
    2. <element name="bitstreams">
      1. <element name="bitstream">
        <field name="name">license_rdf</field>
        <field name="format">application/octet-stream</field>
        <field name="size">908</field>
        <field name="url">https://docusalut.com/bitstreams/7218d6db-0132-4832-a311-e780c5a03a4c/download</field>
        <field name="checksum">0175ea4a2d4caec4bbcc37e300941108</field>
        <field name="checksumAlgorithm">MD5</field>
        <field name="sid">2</field>
        </element>
      </element>
    </element>
  3. <element name="bundle">
    1. <field name="name">TEXT</field>
    2. <element name="bitstreams">
      1. <element name="bitstream">
        <field name="name">000716498400001.pdf.txt</field>
        <field name="originalName">000716498400001.pdf.txt</field>
        <field name="description">Extracted text</field>
        <field name="format">text/plain</field>
        <field name="size">46471</field>
        <field name="url">https://docusalut.com/bitstreams/f8f7760f-7952-4cad-9b19-1de6567d4371/download</field>
        <field name="checksum">170a1dfefd8bd0580228e0a3601893f2</field>
        <field name="checksumAlgorithm">MD5</field>
        <field name="sid">3</field>
        </element>
      </element>
    </element>
  4. <element name="bundle">
    1. <field name="name">THUMBNAIL</field>
    2. <element name="bitstreams">
      1. <element name="bitstream">
        <field name="name">000716498400001.pdf.jpg</field>
        <field name="originalName">000716498400001.pdf.jpg</field>
        <field name="description">IM Thumbnail</field>
        <field name="format">image/jpeg</field>
        <field name="size">20651</field>
        <field name="url">https://docusalut.com/bitstreams/2126acd2-5152-4340-b623-8a679b6d3ef8/download</field>
        <field name="checksum">ffaea5d46a78ca09121cbc7bc00aed6e</field>
        <field name="checksumAlgorithm">MD5</field>
        <field name="sid">4</field>
        </element>
      </element>
    </element>
  </element>
4. <element name="others">
  1. <field name="handle">20.500.13003/19399</field>
  2. <field name="identifier">oai:docusalut.com:20.500.13003/19399</field>
  3. <field name="lastModifyDate">2025-03-13 17:10:52.624</field>
  4. <element name="cc">
    1. <field name="uri">http://creativecommons.org/licenses/by/4.0/</field>
    2. <field name="name">Attribution 4.0 International</field>
    </element>
  5. <element name="access-status">
    1. <field name="value">open.access</field>
    </element>
  </element>
5. <element name="repository">
  1. <field name="url">https://docusalut.com</field>
  2. <field name="name">Docusalut</field>
  3. <field name="mail">docusalut@bibliosalut.com</field>
  </element>
6. <element name="license" />
</metadata>